(Q73384066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742654%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

A novel nitric oxide scavenger in combination with cyclosporine A ameliorates experimental autoimmune encephalomyelitis progression in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742654%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

experimental autoimmune encephalomyelitis

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

1 January 2024

author name string

Ching-San Lai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742654%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Corinne G. Jolivalt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742654

1 January 2024

Randy B. Howard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742654

1 January 2024

Long S. Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742654

1 January 2024

Andrew P. Mizisin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742654

1 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12742654

1 January 2024

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742654%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.elsevier.com/content/article/PII:S0165572803000973?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

https://api.elsevier.com/content/article/PII:S0165572803000973?httpAccept=text/plain

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

Journal of Neuroimmunology

1 January 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742654%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742654%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742654%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

56-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742654%20AND%20SRC:MED&resulttype=core&format=json

Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Relevance of experimental allergic encephalomyelitis to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Biological effects of cyclosporin A: A new antilymphocytic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Cyclosporin A in cadaveric organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Evidence for the production of peroxynitrite in inflammatory CNS demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Peroxynitrite formation within the central nervous system in active multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Cyclosporin A treatment modulates cytokine mRNA expression by inflammatory cells extracted from the spinal cord of rats with experimental autoimmune encephalomyelitis induced by inoculation with myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in lewis rats: Dynamics of cellular mrna expression in the central nervous system and lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Clinical trials of immunosuppression and immunomodulation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Nitric oxide: an endogenous modulator of leukocyte adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Spin trapping of nitric oxide produced in vivo in septic-shock mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Role of interferon regulatory factor 1 in induction of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Cytokines in inflammatory brain lesions: helpful and harmful

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Evidence for an astrocyte-derived vasorelaxing factor with properties similar to nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Review: cytokines and the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

1 reference

7 January 2021

Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Cyclosporin A blocks receptors for HLA-DR antigens on T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Reduction of myocardial nitrosyl complex formation by a nitric oxide scavenger prolongs cardiac allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Multiple sclerosis: immune system molecule expression in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

NOX 100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Randomised double blind controlled trial of cyclosporin in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Extensive peroxynitrite activity during progressive stages of central nervous system inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900097-3

7 January 2021

Combination of cyclosporine A and calcitriol in the treatment of adjuvant arthritis

3

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

Immunosuppressive agents in organ transplantation: past, present, and future

1 January 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

Effects of cyclosporine on the immune system of the mouse. II. Cyclosporine inhibits the effector function of primary T helper cells, but not helper cell priming

1 January 2024

20

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock

1 January 2024

31

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge

1 January 2024

36

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00097-3

1 January 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742654%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference